Director
Eli Lilly and Company
Indianapolis, Indiana
Jennifer A Martin, MS is a Director in Drug Disposition at Eli Lilly and Company in Indianapolis, Indiana. Jennifer designs, analyzes, and interprets studies for the absorption/distribution/metabolism/excretion (ADME) of large molecules with a primary focus on peptides and fusion proteins in support of ADME, pharmacology, and toxicology studies. She provides scientific consultation and expertise on cross-functional program teams to recommend selection of drug candidates for development, design development plans, and prepare for worldwide regulatory submissions.
Disclosure information not submitted.
Development Considerations for Tirzepatide: Drug Disposition Package for Registration
Wednesday, July 15, 2026
8:35 AM - 9:05 AM East Coast USA Time